George Tsirakis

802 total citations
43 papers, 628 citations indexed

About

George Tsirakis is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, George Tsirakis has authored 43 papers receiving a total of 628 indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Hematology, 19 papers in Oncology and 13 papers in Genetics. Recurrent topics in George Tsirakis's work include Multiple Myeloma Research and Treatments (30 papers), Chemokine receptors and signaling (8 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (7 papers). George Tsirakis is often cited by papers focused on Multiple Myeloma Research and Treatments (30 papers), Chemokine receptors and signaling (8 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (7 papers). George Tsirakis collaborates with scholars based in Greece, United States and Russia. George Tsirakis's co-authors include Michael G. Alexandrakis, Constantina A. Pappa, Efstathios N. Stathopoulos, Athanasios Alegakis, Freda Passam, D. Kyriakou, M.G. Alexandrakis, Aekaterini Sfiridaki, Ioannis Neonakis and Katerina Sfiridaki and has published in prestigious journals such as BioMed Research International, Cytokine and Clinical Therapeutics.

In The Last Decade

George Tsirakis

43 papers receiving 620 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
George Tsirakis Greece 17 386 274 229 157 85 43 628
Shihui Ma China 15 292 0.8× 92 0.3× 215 0.9× 201 1.3× 99 1.2× 33 629
Gian Antonio Da Prada Italy 12 269 0.7× 256 0.9× 89 0.4× 134 0.9× 47 0.6× 31 566
Masaharu Nobuyoshi Japan 13 384 1.0× 307 1.1× 424 1.9× 82 0.5× 48 0.6× 22 720
Toshiaki Shirai Japan 15 254 0.7× 289 1.1× 217 0.9× 150 1.0× 71 0.8× 28 685
I Murohashi Japan 16 497 1.3× 187 0.7× 285 1.2× 152 1.0× 131 1.5× 63 806
John Hewson Australia 13 285 0.7× 168 0.6× 265 1.2× 154 1.0× 86 1.0× 19 638
Martin J. Auger United Kingdom 10 213 0.6× 103 0.4× 200 0.9× 77 0.5× 72 0.8× 17 470
Barbara Wysoczańska Poland 13 165 0.4× 105 0.4× 235 1.0× 242 1.5× 47 0.6× 28 654
Chul‐Soo Cho South Korea 12 154 0.4× 87 0.3× 181 0.8× 227 1.4× 40 0.5× 19 602
Debra M. Bensen-Kennedy United States 12 389 1.0× 113 0.4× 142 0.6× 125 0.8× 146 1.7× 19 652

Countries citing papers authored by George Tsirakis

Since Specialization
Citations

This map shows the geographic impact of George Tsirakis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George Tsirakis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George Tsirakis more than expected).

Fields of papers citing papers by George Tsirakis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by George Tsirakis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George Tsirakis. The network helps show where George Tsirakis may publish in the future.

Co-authorship network of co-authors of George Tsirakis

This figure shows the co-authorship network connecting the top 25 collaborators of George Tsirakis. A scholar is included among the top collaborators of George Tsirakis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with George Tsirakis. George Tsirakis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tsirakis, George, et al.. (2015). Correlation of Mast Cell Density With Angiogenic Cytokines in Patients With Active Multiple Myeloma. Clinical Therapeutics. 38(2). 297–301. 5 indexed citations
2.
Alexandrakis, Michael G., Ioannis Neonakis, Constantina A. Pappa, et al.. (2015). Immunohistochemical expression of endoglin offers a reliable estimation of bone marrow neoangiogenesis in multiple myeloma. Journal of Cancer Research and Clinical Oncology. 141(8). 1503–1509. 4 indexed citations
3.
Pappa, Constantina A., et al.. (2015). Mast Cells Influence the Proliferation Rate of Myeloma Plasma Cells. Cancer Investigation. 33(4). 137–141. 9 indexed citations
4.
Alexandrakis, Michael G., et al.. (2015). Interleukin-10 Induces Both Plasma Cell Proliferation and Angiogenesis in Multiple Myeloma. Pathology & Oncology Research. 21(4). 929–934. 48 indexed citations
5.
Alexandrakis, Michael G., Constantina A. Pappa, Αναστασία Παπαδοπούλου, et al.. (2015). Circulating serum levels of IL-20 in multiple myeloma patients: its significance in angiogenesis and disease activity. Medical Oncology. 32(3). 42–42. 8 indexed citations
6.
Alexandrakis, Michael G., et al.. (2014). Circulating levels of soluble Fas ligand reflect disease progression in multiple myeloma. Medical Oncology. 31(5). 953–953. 5 indexed citations
7.
Tsirakis, George, et al.. (2013). Increased serum levels of MIP-1alpha correlate with bone disease and angiogenic cytokines in patients with multiple myeloma. Medical Oncology. 31(1). 778–778. 8 indexed citations
8.
Pappa, Constantina A., et al.. (2013). Serum levels of angiopoietin-2 are associated with the growth of multiple myeloma. Cancer Investigation. 31(6). 385–389. 11 indexed citations
9.
Tsirakis, George, et al.. (2012). Serum concentrations and clinical significance of soluble CD40 ligand in patients with multiple myeloma. Medical Oncology. 29(4). 2396–2401. 8 indexed citations
10.
Tsirakis, George, et al.. (2012). B cell-activating factor: its clinical significance in multiple myeloma patients. Annals of Hematology. 91(9). 1413–1418. 24 indexed citations
11.
Tsirakis, George, et al.. (2012). The relationship between soluble receptor of interleukin-6 with angiogenic cytokines and proliferation markers in multiple myeloma. Tumor Biology. 34(2). 859–864. 8 indexed citations
12.
Tsirakis, George, Constantina A. Pappa, Constantinos Tsioutis, et al.. (2012). Serum BAFF levels are related to angiogenesis and prognosis in patients with multiple myeloma. Leukemia Research. 36(8). 1004–1008. 30 indexed citations
13.
Stylianou, Kostas, George Tsirakis, Elpis Mantadakis, et al.. (2009). Refractory thrombotic thrombocytopenic purpura associated with oral contraceptives and factor V Leiden: a case report. Cases Journal. 2(1). 6611–6611. 2 indexed citations
14.
Neonakis, Ioannis, Michael G. Alexandrakis, Zoe Gitti, et al.. (2008). Miliary tuberculosis with no pulmonary involvement in myelodysplastic syndromes: a curable, yet rarely diagnosed, disease: case report and review of the literature. Annals of Clinical Microbiology and Antimicrobials. 7(1). 8–8. 6 indexed citations
15.
Passam, Freda, Michael G. Alexandrakis, Maria Kafousi, et al.. (2008). Histological expression of angiogenic factors: VEGF, PDGFRα, and HIF-1α in Hodgkin lymphoma. Pathology - Research and Practice. 205(1). 11–20. 36 indexed citations
16.
Pappa, Constantina A., Spiros Miyakis, George Tsirakis, et al.. (2007). Serum levels of Interleukin-15 and Interleukin-10 and their correlation with proliferating cell nuclear antigen in multiple myeloma. Cytokine. 37(2). 171–175. 30 indexed citations
17.
Bizakis, John G., et al.. (2005). Kikuchi's disease: A benign cause of fever and cervical lymphadenopathy. European Journal of Internal Medicine. 16(5). 356–358. 3 indexed citations
18.
Miyakis, Spiros, et al.. (2005). Systemic levels of interleukin-6 and matrix metalloproteinase-9 in patients with multiple myeloma may be useful as prognostic indexes of bone disease. Clinical Chemistry and Laboratory Medicine (CCLM). 43(9). 934–8. 17 indexed citations
19.
Alexandrakis, Michael G., Freda Passam, Constantina A. Pappa, et al.. (2004). Relation between bone marrow angiogenesis and serum levels of angiogenin in patients with myelodysplastic syndromes. Leukemia Research. 29(1). 41–46. 28 indexed citations
20.
Passam, Freda, et al.. (2004). Levels of soluble forms of ICAM and VCAM in patients with myelodysplastic syndromes and their prognostic significance. Clinical & Laboratory Haematology. 26(6). 391–395. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shihui Ma Breakdown of academic impact, for papers by Gian Antonio Da Prada Breakdown of academic impact, for papers by Masaharu Nobuyoshi Breakdown of academic impact, for papers by Toshiaki Shirai Breakdown of academic impact, for papers by I Murohashi Breakdown of academic impact, for papers by John Hewson Breakdown of academic impact, for papers by Martin J. Auger Breakdown of academic impact, for papers by Barbara Wysoczańska Breakdown of academic impact, for papers by Chul‐Soo Cho Breakdown of academic impact, for papers by Debra M. Bensen-Kennedy
Rankless by CCL
2026